C2i Genomics, Inc.
Biotechnology company · New York, United States
C2i Genomics, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2021.
C2i Genomics at a glance
What does C2i Genomics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $50 million sold (2021).
Frequently asked questions about C2i Genomics
Where is C2i Genomics headquartered?
C2i Genomics, Inc. is headquartered in New York, United States.
What does C2i Genomics do?
C2i Genomics, Inc. is a biotechnology company.
When was C2i Genomics founded?
The earliest incorporation on record for C2i Genomics, Inc. is in 2019, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences